Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2019 08:00 ET | Source: Pfenex, Inc.

Pfenex and Alvogen Announce European Medicines Agency Accepts Marketing Authorization Application for PF708

SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) and Alvogen today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization...
May 09, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex Reports First Quarter 2019 Results and Provides Business Update

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
April 25, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex to Announce First Quarter 2019 Financial Results on May 9

SAN DIEGO, April 25, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
April 23, 2019 08:05 ET | Source: Pfenex, Inc.

Pfenex Appoints Dr. Robert Peach to Scientific Advisory Board

SAN DIEGO, April 23, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), today announced the appointment of Robert Peach, Ph.D. to the Pfenex Scientific Advisory Board. “We are very excited...
April 11, 2019 08:05 ET | Source: Pfenex, Inc.

Pfenex Announces Successful Expiration of 45 Day Waiting Period Under Hatch-Waxman Act

SAN DIEGO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
March 27, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex to Participate at the William Blair Late-Stage Therapeutics Conference

SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
March 26, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex to Present at the 18th Annual Needham Healthcare Conference

SAN DIEGO, March 26, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
March 18, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex to Present at the 29th Annual Oppenheimer & Co. Healthcare Conference

SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
March 18, 2019 08:05 ET | Source: Pfenex, Inc.

Pfenex Appoints Dr. Martin B. Brenner as Chief Scientific Officer

SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
March 11, 2019 16:05 ET | Source: Pfenex, Inc.

Pfenex Reports Fourth Quarter and Full Year 2018 Results and Provides Business Update

We believe PF708 is on track to enter the U.S. market as early as Q4 2019, subject to FDA approval and other factors Several significant milestones across the Company’s pipeline are expected in 2019 ...